T. Rowe Price Associates’s Aspira Women's Health Inc. Common Stock AWH Stock Holding History

T. Rowe Price Associates’s Portfolio AWH Stock Details AWH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-4,088	Closed	-$64K	–	3022
2022 Q1	$64K	Buy	4,088 +153	+4%	+$2.65K	﹤0.01%	2900
2021 Q4	$104K	Sell	3,935 -76	-2%	-$2.88K	﹤0.01%	2866
2021 Q3	$196K	Buy	4,011 +2,213	+123%	+$137K	﹤0.01%	2734
2021 Q2	$152K	Sell	1,798 -46	-2%	-$3.95K	﹤0.01%	2781
2021 Q1	$187K	Sell	1,844 -776	-30%	-$85.3K	﹤0.01%	2706
2020 Q4	$264K	Sell	2,620 -561	-18%	-$37.5K	﹤0.01%	2466
2020 Q3	$147K	Buy	+3,181	New	+$163K	﹤0.01%	2480

Other funds holding AWH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

ACM

ACT Capital Management Wayne, Pennsylvania $153M AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

GWM

Greenwich Wealth Management Greenwich, Connecticut $2.45B AUM 39.53% 1-Year Est. Return

Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates's AWH Position: Q2 2022 in Review

T. Rowe Price Associates sold out of Aspira Women's Health Inc. Common Stock (AWH) in Q2 2022, closing a stake of 4,088 shares — an estimated $64K sold.

T. Rowe Price Associates first reported a position in AWH in Q3 2020 and held it in 7 quarters. The position peaked at $264K in Q4 2020. 72 funds tracked by Wall St. Rank hold AWH as of Q2 2022.

T. Rowe Price Associates reported no remaining Aspira Women's Health Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
T. Rowe Price Associates sold 4,088 Aspira Women's Health Inc. Common Stock shares in Q2 2022, an estimated $64K.
T. Rowe Price Associates first reported a position in Aspira Women's Health Inc. Common Stock in Q3 2020 and held it in 7 quarters.
T. Rowe Price Associates's Aspira Women's Health Inc. Common Stock position peaked at $264K in Q4 2020.
72 funds tracked by Wall St. Rank held Aspira Women's Health Inc. Common Stock as of Q2 2022.

Based on T. Rowe Price Associates's 13F filing for Q2 2022, filed 15 Aug 2022.